ArticlePharmacoEconomics - open2024

Estimation of the Clinical, Economic, and Social Burden of Stage IV Non-Small Cell Lung Cancer in Mexico.

Denisse Añorve Bailon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.